Keeping a Close Watch on a Bifurcated Market
We are keeping our eyes peeled for a potential shift in index performance.
It's Time for Bargain Shopping in the Biotech Aisle
Dynavax Technologies, Kala Pharmaceuticals and TherapeuticsMD are three names this biotech investor plans to add exposure to via covered calls.
Chinese Tech Stocks Plunge on Tighter Access to U.S. Markets
Chinese companies looking to list overseas are contending with pressure from U.S. and Chinese regulators, with it impossible to satisfy both.
Thursday's Close Shave, Troubling New Highs and Lows, Peloton Kicks Into Gear
The market came within whiskers of a technical breakdown on Thursday, yet few people seem to know or care.
Indices' Failure to Reflect True Market Action Reaches an Extreme
While headlines shout of new all-time market highs aggressive traders dealing in speculative issues continue to rack up losses.
If You Don't Have Anything Nice to Say About the Market...
Then read this, because I've got something nice to say about it.
Jim Cramer: We Spelled Recovery Wrong This Whole Time
It wasn't an 'L,' or a 'U,' or even a 'V' or 'W.' Here's the letter we were looking for -- and how our failure to see it has thrown things out of whack.
The Dow Is Swimming While the ARKK Is Sinking
The contrast in how the Dow is acting and the this exchange-traded fund is moving is striking.
This Dividend Stock Could Finally Be a Business 'Machine'
IBM has been frustrating as a turnaround name, but it's now pressing the right buttons -- and has a high yield.
Steelmaker Nucor Soars: Here Are Our New Targets
The intense rally in NUE makes it look like a cloud or tech name.